Pay in 4 interest-free payments of $6.73 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
HC: Writing original draft
Liraglutide ( Saxenda ): The first of the FDA-approved GLP-1 agonists, on the market since 2014
Rather than relying on a single isolated pathway, this formulation integrates two highly stable synthetic peptides BPC-157 Arginate Salt and KPV with two lipid-derived homeostatic modulators, Palmitoylethanolamide (PEA) and Tributyrin
It is chemically modified to extend its half-life and duration of action
US$ 27.14
US$ 25.86
US$ 20.71
US$ 27.04
US$ 29.20
US$ 27.58
